Shojaeian Ali, Sanami Samira, Mahmoudvand Shahab, Amini Razieh, Alibakhshi Abbas
Research Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran.
Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran.
GMS Hyg Infect Control. 2025 Jun 16;20:Doc27. doi: 10.3205/dgkh000556. eCollection 2025.
Gastric cancer and peptic ulcers can both be caused by . The complexity of such a bacterium has made it difficult to develop an effective treatment. Thus, a computational approach to developing antigenicity, stability, and safety in vaccines against this pathogen will aid in the management of related diseases.
This investigation chose two proteins, SabA and BabA, as epitope prediction targets, and an immunoinformatics platform was used to create a subunit vaccine against . The best helper T-lymphocyte (HTLs) along with cytotoxic T-lymphocyte (CTLs) epitopes were chosen according to antigenicity, toxicity and allergenicity. The chosen epitopes, suitable linkers, and adjuvants were combined for creating a final vaccine design. The antigenicity, allergenicity, and physicochemical traits of the vaccine were assessed.
The 3D structure of the multi-epitope vaccine was successfully predicted. The results of molecular docking analysis along with molecular dynamics (MD) simulation on the multi-epitope vaccine and immune receptors complex showed the structure has appropriate interaction energy between its two components and good stability. The vaccine candidate was cloned in silico in the pET28a (+) vector successfully in a suitable site.
The results showed that final vaccine design would work well as an effective prophylactic vaccine against . To evaluate vaccine efficacy against the aforementioned bacteria, and trials are required.
胃癌和消化性溃疡都可能由 引起。这种细菌的复杂性使得开发有效的治疗方法变得困难。因此,通过计算方法来开发针对这种病原体的疫苗的抗原性、稳定性和安全性,将有助于相关疾病的管理。
本研究选择了两种蛋白质,即SabA和BabA作为表位预测靶点,并使用免疫信息学平台来创建针对 的亚单位疫苗。根据抗原性、毒性和致敏性选择最佳的辅助性T淋巴细胞(HTLs)以及细胞毒性T淋巴细胞(CTLs)表位。将所选表位、合适的连接子和佐剂组合起来,以创建最终的疫苗设计。评估了疫苗的抗原性、致敏性和理化特性。
成功预测了多表位疫苗的三维结构。对多表位疫苗与免疫受体复合物进行分子对接分析和分子动力学(MD)模拟的结果表明,该结构在其两个组分之间具有适当的相互作用能且稳定性良好。候选疫苗在计算机上成功克隆到pET28a(+)载体的合适位点。
结果表明,最终的疫苗设计作为针对 的有效预防性疫苗将发挥良好作用。为了评估疫苗对上述细菌的疗效,需要进行 试验和 试验。